Cargando…
Adjuvant statin therapy for oesophageal adenocarcinoma: the STAT‐ROC feasibility study
BACKGROUND: Statins inhibit proliferative signalling in oesophageal adenocarcinoma (OAC) and their use is associated with better survival in observational studies. The present study was undertaken to examine the feasibility of assessing adjuvant statin therapy in patients with operable OAC in a phas...
Autores principales: | Alexandre, L., Clark, A. B., Walton, S., Lewis, M. P., Kumar, B., Cheong, E. C., Warren, H., Kadirkamanathan, S. S., Parsons, S. L., Dresner, S. M., Sims, E., Jones, M., Hammond, M., Flather, M., Loke, Y. K., Swart, A. M., Hart, A. R. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
John Wiley & Sons, Ltd
2019
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6996637/ https://www.ncbi.nlm.nih.gov/pubmed/32011825 http://dx.doi.org/10.1002/bjs5.50239 |
Ejemplares similares
-
Supervised exercise after oesophageal cancer surgery: the PERFECT multicentre randomized clinical trial
por: van Vulpen, J K, et al.
Publicado: (2021) -
Impact of tumour histological subtype on chemotherapy outcome in advanced oesophageal cancer
por: Davidson, Michael, et al.
Publicado: (2017) -
Total versus partial posterior fundoplication in the surgical repair of para-oesophageal hernias: randomized clinical trial
por: Analatos, Apostolos, et al.
Publicado: (2022) -
Efficacy of a Standalone Microporous Ceramic Versus Autograft in Instrumented Posterolateral Spinal Fusion: A Multicenter, Randomized, Intrapatient Controlled, Noninferiority Trial
por: Lehr, A. Mechteld, et al.
Publicado: (2020) -
Increasing Fusion Rate Between 1 and 2 Years After Instrumented Posterolateral Spinal Fusion and the Role of Bone Grafting
por: Lehr, A. Mechteld, et al.
Publicado: (2020)